Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
2002 3
2003 2
2004 2
2005 2
2006 1
2007 4
2008 2
2009 4
2010 1
2011 3
2012 7
2013 5
2014 14
2015 8
2016 6
2017 6
2018 4
2019 7
2020 8
2021 5
2022 6
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

93 results

Results by year

Filters applied: . Clear all
Page 1
Immunogenicity and safety of a booster dose of a self-amplifying RNA COVID-19 vaccine (ARCT-154) versus BNT162b2 mRNA COVID-19 vaccine: a double-blind, multicentre, randomised, controlled, phase 3, non-inferiority trial.
Oda Y, Kumagai Y, Kanai M, Iwama Y, Okura I, Minamida T, Yagi Y, Kurosawa T, Greener B, Zhang Y, Walson JL. Oda Y, et al. Among authors: kumagai y. Lancet Infect Dis. 2024 Apr;24(4):351-360. doi: 10.1016/S1473-3099(23)00650-3. Epub 2023 Dec 20. Lancet Infect Dis. 2024. PMID: 38141632 Clinical Trial.
Concentration-QTc analysis for single arm studies.
Orihashi Y, Ohwada S, Kumagai Y. Orihashi Y, et al. Among authors: kumagai y. J Pharmacokinet Pharmacodyn. 2021 Apr;48(2):203-211. doi: 10.1007/s10928-021-09737-0. Epub 2021 Jan 29. J Pharmacokinet Pharmacodyn. 2021. PMID: 33512637
Efficacy and safety of single-dose ivermectin in mild-to-moderate COVID-19: the double-blind, randomized, placebo-controlled CORVETTE-01 trial.
Wada T, Hibino M, Aono H, Kyoda S, Iwadate Y, Shishido E, Ikeda K, Kinoshita N, Matsuda Y, Otani S, Kameda R, Matoba K, Nonaka M, Maeda M, Kumagai Y, Ako J, Shichiri M, Naoki K, Katagiri M, Takaso M, Iwamura M, Katayama K, Miyatsuka T, Orihashi Y, Yamaoka K; CORVETTE-01 Study Group. Wada T, et al. Among authors: kumagai y. Front Med (Lausanne). 2023 May 22;10:1139046. doi: 10.3389/fmed.2023.1139046. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37283627 Free PMC article.
[Arrhythmogenicity].
Kumagai Y. Kumagai Y. Nihon Rinsho. 2012 Aug;70 Suppl 6:593-6. Nihon Rinsho. 2012. PMID: 23156579 Japanese. No abstract available.
Suppressed angiogenesis in kininogen-deficiencies.
Hayashi I, Amano H, Yoshida S, Kamata K, Kamata M, Inukai M, Fujita T, Kumagai Y, Furudate S, Majima M. Hayashi I, et al. Among authors: kumagai y. Lab Invest. 2002 Jul;82(7):871-80. doi: 10.1097/01.lab.0000018885.36823.d6. Lab Invest. 2002. PMID: 12118089 Free article.
93 results